- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 475/12 - Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 475/12
Total number of patents in this class: 33
10-year publication summary
|
1
|
2
|
2
|
1
|
1
|
2
|
3
|
1
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2220 |
9 |
| Merck & Cie | 31 |
5 |
| Boehringer Ingelheim International GmbH | 4493 |
4 |
| Elan Pharmaceuticals, Inc. | 30 |
2 |
| Arthrosi Therapeutics, Inc. | 28 |
2 |
| AstraZeneca AB | 2818 |
1 |
| The Regents of the University of Michigan | 4979 |
1 |
| Vertex Pharmaceuticals Incorporated | 1584 |
1 |
| I-sens, Inc. | 432 |
1 |
| Indian Institute of Science | 351 |
1 |
| OSI Pharmaceuticals, LLC | 49 |
1 |
| Savvipharm Inc | 9 |
1 |
| Tosoh Corporation | 1414 |
1 |
| Sogang University Research & Business Development Foundation | 244 |
1 |
| Tarapeutics Science Inc. | 26 |
1 |
| Hainan Simcere Zaiming Pharmaceutical Co., Ltd. | 38 |
1 |
| Other owners | 0 |